Cargando…

The role of necroptosis in cancer biology and therapy

Apoptosis resistance is to a large extent a major obstacle leading to chemotherapy failure during cancer treatment. Bypassing the apoptotic pathway to induce cancer cell death is considered to be a promising approach to overcoming this problem. Necroptosis is a regulated necrotic cell death modality...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Yitao, Fan, Zhiyao, Luo, Guopei, Yang, Chao, Huang, Qiuyi, Fan, Kun, Cheng, He, Jin, Kaizhou, Ni, Quanxing, Yu, Xianjun, Liu, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532150/
https://www.ncbi.nlm.nih.gov/pubmed/31122251
http://dx.doi.org/10.1186/s12943-019-1029-8
_version_ 1783420953592594432
author Gong, Yitao
Fan, Zhiyao
Luo, Guopei
Yang, Chao
Huang, Qiuyi
Fan, Kun
Cheng, He
Jin, Kaizhou
Ni, Quanxing
Yu, Xianjun
Liu, Chen
author_facet Gong, Yitao
Fan, Zhiyao
Luo, Guopei
Yang, Chao
Huang, Qiuyi
Fan, Kun
Cheng, He
Jin, Kaizhou
Ni, Quanxing
Yu, Xianjun
Liu, Chen
author_sort Gong, Yitao
collection PubMed
description Apoptosis resistance is to a large extent a major obstacle leading to chemotherapy failure during cancer treatment. Bypassing the apoptotic pathway to induce cancer cell death is considered to be a promising approach to overcoming this problem. Necroptosis is a regulated necrotic cell death modality in a caspase-independent fashion and is mainly mediated by Receptor-Interacting Protein 1 (RIP1), RIP3, and Mixed Lineage Kinase Domain-Like (MLKL). Necroptosis serves as an alternative mode of programmed cell death overcoming apoptosis resistance and may trigger and amplify antitumor immunity in cancer therapy. The role of necroptosis in cancer is complicated. The expression of key regulators of the necroptotic pathway is generally downregulated in cancer cells, suggesting that cancer cells may also evade necroptosis to survive; however, in certain types of cancer, the expression level of key mediators is elevated. Necroptosis can elicit strong adaptive immune responses that may defend against tumor progression; however, the recruited inflammatory response may also promote tumorigenesis and cancer metastasis, and necroptosis may generate an immunosuppressive tumor microenvironment. Necroptosis also reportedly promotes oncogenesis and cancer metastasis despite evidence demonstrating its antimetastatic role in cancer. In addition, necroptotic microenvironments can direct lineage commitment to determine cancer subtype development in liver cancer. A plethora of compounds and drugs targeting necroptosis exhibit potential antitumor efficacy, but their clinical feasibility must be validated. Better knowledge of the necroptotic pathway mechanism and its physiological and pathological functions is urgently required to solve the remaining mysteries surrounding the role of necroptosis in cancer. In this review, we briefly introduce the molecular mechanism and characteristics of necroptosis, the interplay between necroptosis and other cell death mechanisms, crosstalk of necroptosis and metabolic signaling and detection methods. We also summarize the intricate role of necroptosis in tumor progression, cancer metastasis, prognosis of cancer patients, cancer immunity regulation, cancer subtype determination and cancer therapeutics.
format Online
Article
Text
id pubmed-6532150
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65321502019-05-28 The role of necroptosis in cancer biology and therapy Gong, Yitao Fan, Zhiyao Luo, Guopei Yang, Chao Huang, Qiuyi Fan, Kun Cheng, He Jin, Kaizhou Ni, Quanxing Yu, Xianjun Liu, Chen Mol Cancer Review Apoptosis resistance is to a large extent a major obstacle leading to chemotherapy failure during cancer treatment. Bypassing the apoptotic pathway to induce cancer cell death is considered to be a promising approach to overcoming this problem. Necroptosis is a regulated necrotic cell death modality in a caspase-independent fashion and is mainly mediated by Receptor-Interacting Protein 1 (RIP1), RIP3, and Mixed Lineage Kinase Domain-Like (MLKL). Necroptosis serves as an alternative mode of programmed cell death overcoming apoptosis resistance and may trigger and amplify antitumor immunity in cancer therapy. The role of necroptosis in cancer is complicated. The expression of key regulators of the necroptotic pathway is generally downregulated in cancer cells, suggesting that cancer cells may also evade necroptosis to survive; however, in certain types of cancer, the expression level of key mediators is elevated. Necroptosis can elicit strong adaptive immune responses that may defend against tumor progression; however, the recruited inflammatory response may also promote tumorigenesis and cancer metastasis, and necroptosis may generate an immunosuppressive tumor microenvironment. Necroptosis also reportedly promotes oncogenesis and cancer metastasis despite evidence demonstrating its antimetastatic role in cancer. In addition, necroptotic microenvironments can direct lineage commitment to determine cancer subtype development in liver cancer. A plethora of compounds and drugs targeting necroptosis exhibit potential antitumor efficacy, but their clinical feasibility must be validated. Better knowledge of the necroptotic pathway mechanism and its physiological and pathological functions is urgently required to solve the remaining mysteries surrounding the role of necroptosis in cancer. In this review, we briefly introduce the molecular mechanism and characteristics of necroptosis, the interplay between necroptosis and other cell death mechanisms, crosstalk of necroptosis and metabolic signaling and detection methods. We also summarize the intricate role of necroptosis in tumor progression, cancer metastasis, prognosis of cancer patients, cancer immunity regulation, cancer subtype determination and cancer therapeutics. BioMed Central 2019-05-23 /pmc/articles/PMC6532150/ /pubmed/31122251 http://dx.doi.org/10.1186/s12943-019-1029-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Gong, Yitao
Fan, Zhiyao
Luo, Guopei
Yang, Chao
Huang, Qiuyi
Fan, Kun
Cheng, He
Jin, Kaizhou
Ni, Quanxing
Yu, Xianjun
Liu, Chen
The role of necroptosis in cancer biology and therapy
title The role of necroptosis in cancer biology and therapy
title_full The role of necroptosis in cancer biology and therapy
title_fullStr The role of necroptosis in cancer biology and therapy
title_full_unstemmed The role of necroptosis in cancer biology and therapy
title_short The role of necroptosis in cancer biology and therapy
title_sort role of necroptosis in cancer biology and therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532150/
https://www.ncbi.nlm.nih.gov/pubmed/31122251
http://dx.doi.org/10.1186/s12943-019-1029-8
work_keys_str_mv AT gongyitao theroleofnecroptosisincancerbiologyandtherapy
AT fanzhiyao theroleofnecroptosisincancerbiologyandtherapy
AT luoguopei theroleofnecroptosisincancerbiologyandtherapy
AT yangchao theroleofnecroptosisincancerbiologyandtherapy
AT huangqiuyi theroleofnecroptosisincancerbiologyandtherapy
AT fankun theroleofnecroptosisincancerbiologyandtherapy
AT chenghe theroleofnecroptosisincancerbiologyandtherapy
AT jinkaizhou theroleofnecroptosisincancerbiologyandtherapy
AT niquanxing theroleofnecroptosisincancerbiologyandtherapy
AT yuxianjun theroleofnecroptosisincancerbiologyandtherapy
AT liuchen theroleofnecroptosisincancerbiologyandtherapy
AT gongyitao roleofnecroptosisincancerbiologyandtherapy
AT fanzhiyao roleofnecroptosisincancerbiologyandtherapy
AT luoguopei roleofnecroptosisincancerbiologyandtherapy
AT yangchao roleofnecroptosisincancerbiologyandtherapy
AT huangqiuyi roleofnecroptosisincancerbiologyandtherapy
AT fankun roleofnecroptosisincancerbiologyandtherapy
AT chenghe roleofnecroptosisincancerbiologyandtherapy
AT jinkaizhou roleofnecroptosisincancerbiologyandtherapy
AT niquanxing roleofnecroptosisincancerbiologyandtherapy
AT yuxianjun roleofnecroptosisincancerbiologyandtherapy
AT liuchen roleofnecroptosisincancerbiologyandtherapy